(Post-pandemic Era)-Global Medical Bionics Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

  • Report Code : XYZ2131745
  • Published On: Nov, 2020
  • Category : Medical Devices
  • Pages : 117


  • As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.


    Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.

    In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.

    Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.

    Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Medical Bionics market in this environment.


    In terms of revenue, this research report indicated that the global Medical Bionics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Medical Bionics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.


    The Abbott aims at producing XX Medical Bionics in 2020, with XX % production to take place in global market, Boston Scientific Corporation accounts for a volume share of XX %.


    Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Medical Bionics Market Include by

    China

    EU

    USA

    Japan

    India

    Southeast Asia

    South America

    Competitive Analysis; Who are the Major Players in Medical Bionics Market

    Abbott

    Boston Scientific Corporation

    Cochlear

    LivaNova

    Medtronic

    Orthofix Holdings

    ssur Corporate

    Retina Implant

    Sonova

    SECOND SIGHT

    SynCardia Systems

    William Demant Holding


    Major Type of Medical Bionics Covered in report:

    Vision Bionics/Bionic Eye

    Ear Bionics

    Orthopedic Bionics

    Cardiac Bionics

    Neural/Brain Bionics

    Application Segments Covered in report

    Implantable Bionics

    External Bionics

    Application 3


    For any other requirements, please feel free to contact us and we will provide you customized report.


     

  • With tables and figures helping analyze worldwide (Post pandemic Era) Global Medical Bionics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Global Medical Bionics Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

    1 Market Scope

    1.1 Product Details and Introduction

    1.1.1 Vision Bionics/Bionic Eye -Product Introduction and Major Manufacturers
    1.1.2 Ear Bionics -Product Introduction and Major Manufacturers
    1.1.3 Orthopedic Bionics -Product Introduction and Major Manufacturers
    1.1.4 Cardiac Bionics -Product Introduction and Major Manufacturers
    1.1.5 Neural/Brain Bionics -Product Introduction and Major Manufacturers

    1.2 Market Snapshot

    1.2.1 Major Companies Overview
    1.2.2 Market Concentration
    1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

    2 Global Medical Bionics Market Assessment, by Segmentation

    2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)

    2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)

    2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)


    3 Regional Market Analysis

    3.1 China Medical Bionics Market

    3.1.1 Top Companies leading Medical Bionics Development in China (2015-2020)
    3.1.2 Sales Value of Major Company in China Market (2015-2020)
    3.1.3 China Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.1.4 Sales in China Market, by Type (2015-2026)

    3.2 EU Medical Bionics Market

    3.2.1 Top Companies leading Medical Bionics Development in EU (2015-2020)
    3.2.2 Sales Value of Major Company in EU Market (2015-2020)
    3.2.3 EU Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.2.4 Sales in EU Market, by Type (2015-2026)

    3.3 USA Medical Bionics Market

    3.3.1 Top Companies leading Medical Bionics Development in USA (2015-2020)
    3.3.2 Sales Value of Major Company in USA Market (2015-2020)
    3.3.3 USA Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.3.4 Sales in USA Market, by Type (2015-2026)

    3.4 Japan Medical Bionics Market

    3.4.1 Top Companies leading Medical Bionics Development in Japan (2015-2020)
    3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
    3.4.3 Japan Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.4.4 Sales in Japan Market, by Type (2015-2026)

    3.5 India Medical Bionics Market

    3.5.1 Top Companies leading Medical Bionics Development in India (2015-2020)
    3.5.2 Sales Value of Major Company in India Market (2015-2020)
    3.5.3 India Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.5.4 Sales in India Market, by Type (2015-2026)

    3.6 Southeast Asia Medical Bionics Market

    3.6.1 Top Companies leading Medical Bionics Development in Southeast Asia (2015-2020)
    3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
    3.6.3 Southeast Asia Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
    3.7 South America Medical Bionics Market
    3.7.1 Top Companies leading Medical Bionics Development in South America (2015-2020)
    3.7.2 Sales Value of Major Company in South America Market (2015-2020)
    3.7.3 South America Medical Bionics Price (USD/Unit), by Type (2019-2020)
    3.7.4 Sales in South America Market, by Type (2015-2026)

    4 Value Chain (Impact of COVID-19)

    4.1 Medical Bionics Value Chain Analysis

    4.1.1 Upstream
    4.1.2 Downstream

    4.2 COVID-19 Impact on Medical Bionics Industry

    4.2.1 Industrial Policy Issued Under the Epidemic Situation

    4.3 Cost-Under the Epidemic Situation

    4.3.1 Cost of Raw Material

    4.4 Channel Analysis

    4.4.1 Distribution Channel-Under the Epidemic Situation
    4.4.2 Distributors

    5 Regional Market Forecast (2021-2026)

    5.1 Global Medical Bionics Sales and Growth Rate (2021-2026)

    5.2 Global Medical Bionics Sales Value and Growth Rate (2021-2026)


    6 Medical Bionics Competitive Analysis

    6.1 Abbott

    6.1.1 Abbott Company Profiles
    6.1.2 Abbott Product Introduction
    6.1.3 Abbott Medical Bionics Production, Revenue (2015-2020)
    6.1.4 SWOT Analysis

    6.2 Boston Scientific Corporation

    6.2.1 Boston Scientific Corporation Company Profiles
    6.2.2 Boston Scientific Corporation Product Introduction
    6.2.3 Boston Scientific Corporation Medical Bionics Production, Revenue (2015-2020)
    6.2.4 SWOT Analysis

    6.3 Cochlear

    6.3.1 Cochlear Company Profiles
    6.3.2 Cochlear Product Introduction
    6.3.3 Cochlear Medical Bionics Production, Revenue (2015-2020)
    6.3.4 SWOT Analysis

    6.4 LivaNova

    6.4.1 LivaNova Company Profiles
    6.4.2 LivaNova Product Introduction
    6.4.3 LivaNova Medical Bionics Production, Revenue (2015-2020)
    6.4.4 SWOT Analysis

    6.5 Medtronic

    6.5.1 Medtronic Company Profiles
    6.5.2 Medtronic Product Introduction
    6.5.3 Medtronic Medical Bionics Production, Revenue (2015-2020)
    6.5.4 SWOT Analysis

    6.6 Orthofix Holdings

    6.6.1 Orthofix Holdings Company Profiles
    6.6.2 Orthofix Holdings Product Introduction
    6.6.3 Orthofix Holdings Medical Bionics Production, Revenue (2015-2020)
    6.6.4 SWOT Analysis
    6.7 ssur Corporate
    6.7.1 ssur Corporate Company Profiles
    6.7.2 ssur Corporate Product Introduction
    6.7.3 ssur Corporate Medical Bionics Production, Revenue (2015-2020)
    6.7.4 SWOT Analysis
    6.8 Retina Implant
    6.8.1 Retina Implant Company Profiles
    6.8.2 Retina Implant Product Introduction
    6.8.3 Retina Implant Medical Bionics Production, Revenue (2015-2020)
    6.8.4 SWOT Analysis
    6.9 Sonova
    6.9.1 Sonova Company Profiles
    6.9.2 Sonova Product Introduction
    6.9.3 Sonova Medical Bionics Production, Revenue (2015-2020)
    6.9.4 SWOT Analysis

    6.10 SECOND SIGHT

    6.10.1 SECOND SIGHT Company Profiles
    6.10.2 SECOND SIGHT Product Introduction
    6.10.3 SECOND SIGHT Medical Bionics Production, Revenue (2015-2020)
    6.10.4 SWOT Analysis
    6.11 SynCardia Systems
    6.12 William Demant Holding

    7 Conclusion

     

  • The (Post pandemic Era) Global Medical Bionics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          What trends are influencing the growth of the (Post pandemic Era) Global Medical Bionics Market?

          New players are entering the (Post pandemic Era) Global Medical Bionics Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.

          What is the expected rate of growth in the (Post pandemic Era) Global Medical Bionics Market?

          From 2024 to 2029, the (Post pandemic Era) Global Medical Bionics Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.

          What is really changing the (Post pandemic Era) Global Medical Bionics Market behavior?

          Consumer behavior changes will reshape the entire decision-making process and companies in the (Post pandemic Era) Global Medical Bionics Industry will need to adapt quickly.

          What are the primary data sources used to evaluate the (Post pandemic Era) Global Medical Bionics Market sizing?

          The majority of data for the (Post pandemic Era) Global Medical Bionics Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.

          Our Clients